as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
1.13%
Downside
2.71%
Upside
52 Week's Low
52 Week's High
38.80%
Downside
15.38%
Upside
Check Arbutus Biopharma Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$868.4M
EPS (TTM)
-0.253
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-9.38
Industry PE ratio
-3.9281873111782475
P/B Ratio
0PEG Ratio
0EBITDA
-43.2M
Revenue (TTM)
15.4M
Profit Margin
0.00%
Return On Equity TTM
573700.00%
Track how Arbutus Biopharma Corporation P/E has moved over time to understand its valuation trends.
Arbutus Biopharma Corporation in the last 5 years
Lowest (0.00x)
September 17, 2025
Today (-9.38x)
September 17, 2025
Industry (-3.93x)
September 17, 2025
Highest (0.00x)
September 17, 2025
Today’s Price to Earnings Ratio: -9.38x
Compare market cap, revenue, PE, and other key metrics of Arbutus Biopharma Corporation with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $868.4M | 47.65% | -9.38 | 0.00% | |
BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
NA | $39.0B | NA | NA | -3.89% | |
BUY | $100.3B | 44.17% | 27.85 | 31.86% | |
BUY | $59.6B | 1.78% | 14.1 | 31.37% |
The Arbutus Biopharma Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Arbutus Biopharma Corporation investment value today
Current value as on today
₹1,12,932
Returns
₹12,932
(+12.93%)
Returns from Arbutus Biopharma Corporation Stock
₹8,333 (+8.33%)
Dollar Returns*
₹4,598 (+4.6%)
Based on 11 analysts
81.82%
Buy
18.18%
Hold
0.00%
Sell
Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Arbutus Biopharma Corporation. Average target price of $5.25
Get share price movements and forecasts by analysts on Arbutus Biopharma Corporation.
What analysts predicted
15.81%UPSIDE
Target Price
$5.25
Current Price
$4.42
Analyzed by
11 Analysts
Target
$5.25
Arbutus Biopharma Corporation target price $5.25, a slight upside of 15.81% compared to current price of $4.42. According to 11 analysts rating.
Search interest for Arbutus Biopharma Corporation Stock has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 4 quarters, 1.33M → 10.73M (in $), with an average increase of 36.4% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, -24.52M → 2.52M (in $), with an average increase of 1072.1% per quarter
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 60.3%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 18.3%
Price Dip
In the last 7 days, ABUS stock has moved down by -4.8%
Organisation | Arbutus Biopharma Corporation |
Headquarters | 701 Veterans Circle, Warminster, PA, United States, 18974 |
Industry | Health Technology |
CEO | Ms. Lindsay Androski J.D., M.B.A. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Lindsay Androski J.D., M.B.A. | President, CEO & Chairman |
Mr. Tuan Nguyen | Chief Financial Officer |
Mr. Andrew J. Sung | General Counsel |
Mr. R. Hector Mackay-Dunn B.A., J.D., L.L.B., Q.C. | Corporate Secretary |
Arbutus Biopharma Corporation share price today is $4.42 as on at the close of the market. Arbutus Biopharma Corporation share today touched a day high of $4.54 and a low of $4.37.
Arbutus Biopharma Corporation share touched a 52 week high of $5.1 on and a 52 week low of $2.71 on . Arbutus Biopharma Corporation stock price today i.e. is closed at $4.42,which is 13.33% down from its 52 week high and 63.40% up from its 52 week low.
Arbutus Biopharma Corporation market capitalisation is $0.00T as on .
Indian investors can start investing in Arbutus Biopharma Corporation (ABUS) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Arbutus Biopharma Corporation stock (as per the Rupee-Dollar exchange rate as on ).
Based on Arbutus Biopharma Corporation share’s latest price of $4.42 as on September 18, 2025 at 1:29 am IST, you will get 2.2624 shares of Arbutus Biopharma Corporation. Learn more about
fractional shares .
Arbutus Biopharma Corporation stock has given 47.65% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?